封面
市场调查报告书
商品编码
1461343

合成生物学市场:按产品、按技术、按最终用户、按地区

Synthetic Biology Market, By Product, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

合成生物学市场预计到2024年将达到178.8亿美元,预计到2031年将达到730.8亿美元,2024年至2031年的复合年增长率为22.3%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 178.8亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024-2030/2031复合年增长率 22.30% 2030/2031 年预测值 730.8亿美元
按地区分類的合成生物市场份额 (%) (2024)
合成生物市场-IMG1

合成生物学是将工程原理应用于生物学的新兴领域。此部分涉及新型人工生物途径、生物体、装置的设计和构建,或现有自然生物系统的重新设计。合成生物学的主要发展包括燃料、化学品和材料的先进生物製造技术的开发,以及用于农业、製药和环境解决方案的人造生物体的开发。研究人员正在致力于开发人工生物系统,以实现更有效、更环保的生产过程。 DNA序列测定、基因组装和编辑技术的进步正在推动这一领域的快速发展,有可能解决医学、能源和环境领域许多紧迫的全球挑战。

市场动态:

全球合成生物学市场的驱动因素包括该领域研发资金和投资的增加、DNA定序和基因编辑技术的进步、生物製药需求的不断增长以及代谢工程等技术的发展。正在製定行业标准,以确保合成生物学的负责任和安全应用。然而,有关基因改造生物的监管问题和伦理问题可能会限制市场成长。合成生物学描述了应对多个领域挑战的机会,包括药物发现、工业生物製造和环境修復。开拓商业应用、国际合作研究以及提高 DNA 合成和基因组工程的成本效率将支持市场扩张。

本研究的主要特点

  • 该报告对全球合成生物学市场进行了详细分析,并提出了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个细分市场的潜在收益成长机会,并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 该报告根据公司亮点、产品系列、主要亮点、业绩和策略等参数,介绍了全球合成生物学市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 合成生物学全球市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球合成生物学市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件

第二章 市场概况

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 市场机会蓝图

第 3 章主要见解

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • PEST分析
  • 波特分析
  • 技术进步
  • 合併、收购和合作场景
  • 最近的产品核可
  • 进出口分析
  • 监管场景
  • 价格分析
  • COVID-19 影响分析
  • 製造能力
  • 经销商状况
  • 投资金筹措
  • 品牌映射
  • 比赛简介
  • 企业定位分析
  • 热图分析

第四章全球合成生物市场,依产品,2019-2031

  • 介绍
  • 寡核苷酸
  • 酵素
  • 合成细胞
  • 底盘有机体
  • 其他的

第五章全球合成生物市场,依技术划分,2019-2031

  • 介绍
  • 基因组工程
  • PCR技术
  • 生物加工技术
  • 新一代定序技术
  • 生物资讯学
  • 奈米科技
  • 其他的

第六章 全球合成生物市场,依最终使用者划分,2019-2031

  • 介绍
  • 製药公司
  • 生技公司
  • 首席行销长和首席研究官
  • 其他的

第七章2019-2031年全球合成生物市场(按地区)

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 波湾合作理事会
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第八章 竞争格局

  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

第9章 盛衰

  • 繁荣与衰落
  • 综合机会图

第10章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI112

The synthetic biology market is estimated to be valued at USD 17.88 Bn in 2024 and is expected to reach USD 73.08 Bn by 2031, growing at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 17.88 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 22.30% 2030/2031 Value Projection: US$ 73.08 Bn
Synthetic Biology Market Share (%), By Region, 2024
Synthetic Biology Market - IMG1

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics:

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global synthetic biology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

  • Product:
    • Oligonucleotides
    • Enzymes
    • Synthetic Cells
    • Chassis Organism
    • Others
  • Technology:
    • Genome Engineering
    • PCR Technology
    • Bioprocessing Technology
    • NGS Technology
    • Bioinformatics
    • Nanotechnology
    • Others
  • End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • CMO & CRO
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • Synbio Technologies
    • Merck KGaA
    • Agilent Technologies Inc.
    • GenScript
    • Amyris
    • Eurofins Genomics GmbH
    • Integrated DNA Technologies Inc.
    • Codexis Inc.
    • EnBiotix Inc.
    • Synthego
    • New England Biolabs (UK) Ltd.
    • Scarab Genomics LLC
    • Genomatica Inc.
    • Novonesis Group
    • Bota Bio
    • Creative Biogene
    • Illumina, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Synthetic Biology Market, By Product, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Oligonucleotides, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Enzymes, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Synthetic Cells, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Chassis Organism, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Synthetic Biology Market, By Technology, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Genome Engineering, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • PCR Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Bioprocessing Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • NGS Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Bioinformatics, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Nanotechnology , 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Synthetic Biology Market, By End User, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Pharmaceutical Companies, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Biotechnology Companies, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • CMO & CRO, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Synthetic Biology Market, By Region, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Asean
  • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • GCC
  • Israel
  • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
  • South Africa
  • North Africa
  • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2024 - Global
  • Company Profiles - Global Synthetic Biology Market
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

9. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact